Citalopram and metacognitive therapy for depressive symptoms and cognitive emotion regulation in patients with major depressive disorder: A randomized controlled trial

Citalopram and metacognitive therapy for depressive symptoms and cognitive emotion regulation in patients with major depressive disorder: A randomized controlled trial

BACKGROUND: Metacognitive therapy (MCT) is a new psychotherapy for depression. This study was conducted to compare the effectiveness of citalopram and MCT on major depressive disorders (MDDs). MATERIALS AND METHODS: A total of 36 patients with MDD were randomly assigned into three groups of citalopr...

Full description

Bibliographic Details
Main Authors: Gholam Reza Kheirabadi, Zahra Yousefian, Fatemeh Zargar, Mahboobe Bahrami, Mohammad R Maracy
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Journal of Education and Health Promotion
Subjects:
citalopram
emotional regulation
major depressive disorder
metacognition
Online Access:http://www.jehp.net/article.asp?issn=2277-9531;year=2020;volume=9;issue=1;spage=6;epage=6;aulast=Kheirabadi

Similar Items

Similar Items